🔗 Share this article

A shadow economy for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust market exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and claims of rapid UK delivery. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Worries

However, physicians and chemists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to individuals administering products of unknown origin.

Some professionals said the demand for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, risking fines, legal action or prison.

Service Reaction and Material Removal

According to the social media company, the platform has removed violative content and prohibited associated hashtags and search suggestions. The company said it was committed to maintaining the platform secure and investing in enhancing compliance measures.

Digital Trading Activities

Research also discovered groups with up to nine thousand members marketing the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with images of slimming results, positive testimonials and detailed instructions for mixing or administering at home.

Within minutes of joining one community, a seller posted WhatsApp details, where most transactions take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, medical conditions or past usage.

Item Details and Pricing

Within these groups, messages show black plastic parcels with Royal Mail labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled pens usually priced at £160 for 20mg. When asked how long a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram said it regularly moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they can’t verify. Even if the science behind retatrutide is valid, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her team has already encountered patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to possibly serious health risks”.